Lucid Diagnostics Q1 Earnings Call Highlights

2 days ago 11

MarketBeat

Thu, May 14, 2026 astatine 12:10 PM CDT 7 min read

Key Points

  • October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard trial measurement supra its pre-Medicare people range, portion absorption said it continues to await a Medicare section sum determination and is expanding efforts with the Department of Veterans Affairs, commercialized payers and wellness systems.

Chairman and Chief Executive Officer Dr. Lishan Aklog said the institution performed 3,177 EsoGuard tests successful the 4th and generated $1.3 cardinal successful revenue. He said gross was down somewhat successful proportionality to volume, which declined from the 4th fourth but remained supra the company’s stated people scope of 2,500 to 3,000 tests during the pre-Medicare period.

→ Rocket Lab Just Hit a New All-Time High—Time to Buy oregon Let It Breathe?

Aklog said Lucid besides strengthened its equilibrium expanse done an underwritten nationalist offering of communal banal that netted astir $16.8 cardinal successful proceeds. He said the financing accrued the company’s pro forma currency presumption to astir $45 cardinal astatine the extremity of the archetypal 4th and extended its currency runway “well into 2027.”

Medicare determination remains cardinal absorption

Management repeatedly emphasized that Medicare sum remains the company’s cardinal near-term catalyst. Aklog said Lucid continues to person assurance successful the Medicare section sum determination, oregon LCD, process contempt delays.

→ MP Materials Is Quietly Building a Rare Earth Powerhouse

“We proceed to person our assurance that this is simply a near-term effect truly hasn't wavered astatine all,” Aklog said. He characterized the hold arsenic logistical alternatively than substantive, adding during the question-and-answer league that thing successful the company’s conversations has raised concerns astir the likelihood of a affirmative draught decision.

In effect to a question from a BTIG expert astir MolDX, Aklog said Lucid continues to person ongoing dialog with enactment but does not person “concrete oregon circumstantial information” connected timing. He said the company’s assurance is based connected the result of the nationalist Contractor Advisory Committee gathering and follow-up conversations related to that meeting.

Read Entire Article